Immune cell-based cardiovascular risk assessment: spotlight on the neutrophil-lymphocyte ratio

Hendrik B. Sager; Wolfgang Koenig

doi:10.1093/eurheartj/ehaa1104

Immune cell-based cardiovascular risk assessment: spotlight on the neutrophil-lymphocyte ratio

Hendrik B. Sager
, Wolfgang Koenig

Medicine and Health

Partner Site Munich Heart Alliance
Technical University of Munich

Research output: Contribution to journal › Review article › peer-review

11 Scopus citations

Original language	English
Pages (from-to)	904-906
Number of pages	3
Journal	European Heart Journal
Volume	42
Issue number	9
DOIs	https://doi.org/10.1093/eurheartj/ehaa1104
State	Published - 1 Mar 2021

Access to Document

10.1093/eurheartj/ehaa1104

Cite this

@article{4ae684f4281e442fbddcb8171cbfd368,

title = "Immune cell-based cardiovascular risk assessment: spotlight on the neutrophil-lymphocyte ratio",

author = "Sager, \{Hendrik B.\} and Wolfgang Koenig",

note = "Funding Information: H.B.S. has received funding from the European Research Council under the European Union{\textquoteright}s Horizon 2020 Research and Innovation Programme (STRATO, grant agreement no. 759272), the {\textquoteleft}Else-Kr{\"o}ner-Fresenius-Stiftung{\textquoteright} (2020\_EKSE.07), the {\textquoteleft}Deutsche Herzstiftung{\textquoteright} (F/28/17), and {\textquoteleft}Deutsche Forschungsgemeinschaft (DFG){\textquoteright} (SA 1668/5-1). W.K. has received funding from the European Research Area Network on Cardiovascular Diseases (ERA-CVD) grant (ERA CVD JTC2017): OPERATION, elucidate monocyte phenotype to predict arterial wall inflammation (2018–2021). ",

year = "2021",

month = mar,

day = "1",

doi = "10.1093/eurheartj/ehaa1104",

language = "English",

volume = "42",

pages = "904--906",

journal = "European Heart Journal",

issn = "0195-668X",

publisher = "Oxford University Press",

number = "9",

}

TY - JOUR

T1 - Immune cell-based cardiovascular risk assessment

T2 - spotlight on the neutrophil-lymphocyte ratio

AU - Sager, Hendrik B.

AU - Koenig, Wolfgang

N1 - Funding Information: H.B.S. has received funding from the European Research Council under the European Union’s Horizon 2020 Research and Innovation Programme (STRATO, grant agreement no. 759272), the ‘Else-Kröner-Fresenius-Stiftung’ (2020_EKSE.07), the ‘Deutsche Herzstiftung’ (F/28/17), and ‘Deutsche Forschungsgemeinschaft (DFG)’ (SA 1668/5-1). W.K. has received funding from the European Research Area Network on Cardiovascular Diseases (ERA-CVD) grant (ERA CVD JTC2017): OPERATION, elucidate monocyte phenotype to predict arterial wall inflammation (2018–2021).

PY - 2021/3/1

Y1 - 2021/3/1

UR - https://www.scopus.com/pages/publications/85102657440

U2 - 10.1093/eurheartj/ehaa1104

DO - 10.1093/eurheartj/ehaa1104

M3 - Review article

C2 - 33421053

AN - SCOPUS:85102657440

SN - 0195-668X

VL - 42

SP - 904

EP - 906

JO - European Heart Journal

JF - European Heart Journal

IS - 9

ER -

Immune cell-based cardiovascular risk assessment: spotlight on the neutrophil-lymphocyte ratio

Access to Document

Other files and links

Cite this